Process for preparing rhodanine-3-acetic acid: a key intermediated of epalrestat
WO2007074391A2
Preparation of a key intermediate in the synthesis of rosuvastatin
WO2006070244A2
A process for the preparation of zaleplon
WO2006027658A2
Process for the preparation of sertraline hydrochloride form ii
WO2005023758A2
Process for the preparation of losartan potassium form i
US2009137633A1
Stable pharmaceutical composition of rabeprazole
AU2003208510A8
Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease)
AU2003209544A8
Use of mycobacterium w in the treatment of asthama(obstructive lung disease)
WO03075825A2
The method of treating tuberculosis
BR0303367A
Mycobacterium w cells, pharmaceutically acceptable carrier, preservative, mycobacterium w disruption, solvent extraction, enzymes used for enzymatic extraction of mycobacterium w cells, adjuvant, pharmaceutical composition, surfactant, and surfactant concentration of the process of making a composition pharmaceutical for the administration of tuberculosis
WO03063897A1
Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO03063896A1
Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
AU2002353366A1
The process of manufacturing a pharmaceutical composition useful for management of cancer
WO03013481A1
The process of manufacturing pharmaceutical composition with increased content of poorly soluble pharmaceutical ingredients
WO02085394A1
The process of preparing the topical anti-inflammatory/analgesic preparation
US2006193875A1
Method of treating human-immunodeficiency virus (HIV) disease infection
WO03015752A1
The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect
EA005672B1
Chemosensitizer
AP200001977A0
The process for manufacturing topical opthalmic preparations without systemic effects
AU2541199A
The process for manufacturing formulation of topical beta blockers with improved efficacy
